Huang Michael F. (CIK 2019992) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-18). Recent activity: Sell SLNO (39,823 shares), Sell SLNO (4,256 shares), Sell SLNO (1,838 shares), Sell SLNO (488 shares), Buy SLNO (10,400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 39,823 | $0 |
| 2026-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 4,256 | $127,850 |
| 2026-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 1,838 | $57,052 |
| 2026-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 488 | $15,479 |
| 2026-01-23 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Buy | 10,400 | $0 |
| 2025-12-17 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 812 | $40,559 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 19 | $1,380 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 371 | $24,475 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 604 | $40,341 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 1,098 | $74,335 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 1,444 | $99,333 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 836 | $58,386 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 86 | $6,083 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 125 | $8,968 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Buy | 10,000 | $219,300 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Sell | 10,000 | $700,300 |
| 2025-01-23 | SOLENO THERAPEUTICS INC (SLNO) | Sr. VP of Clinical Development | Buy | 6,400 | $0 |
Source: SEC Form 4 filings · as of 2026-05-18